Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,886 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lymph-node ratio as a risk factor for recurrence following neoadjuvant docetaxel, cisplatin, and 5-fluorouracil therapy for locally advanced esophageal squamous cell carcinoma.
Tamba M, Okamura A, Osumi H, Imamura Y, Kanamori J, Ogura M, Fukuoka S, Yoshino K, Udagawa S, Wakatsuki T, Shinozaki E, Watanabe M, Yamaguchi K, Chin K, Ooki A. Tamba M, et al. Among authors: imamura y. Esophagus. 2025 Jan 4. doi: 10.1007/s10388-024-01103-6. Online ahead of print. Esophagus. 2025. PMID: 39755858
Stone at the same location for 2 months predicts impacted stones and stone-free status after shock wave lithotripsy for ureteral stones: A Funabashi clinic expert study.
Nozumi K, Sakamoto S, Zhao X, Pae S, Tamura T, Taguchi K, Yamada Y, Goto Y, Imamura Y, Sazuka T, Awa Y, Yasui T, Nozumi K, Naya Y, Akakura K, Ichikawa T. Nozumi K, et al. Among authors: imamura y. Int J Urol. 2024 Dec 30. doi: 10.1111/iju.15662. Online ahead of print. Int J Urol. 2024. PMID: 39740093
Public assistance and survival equality in patients with EGFR mutation-positive lung cancer.
Uryu K, Imamura Y, Shimoyama R, Mase T, Fujimura Y, Hayashi M, Ohtaki M, Otani K, Hibino M, Horiuchi S, Fukui T, Fukai R, Chihara Y, Iwase A, Yamada N, Tamura Y, Harada H, Tsuya A, Okabe T, Fukuoka M, Minami H. Uryu K, et al. Among authors: imamura y. Jpn J Clin Oncol. 2024 Dec 1:hyae167. doi: 10.1093/jjco/hyae167. Online ahead of print. Jpn J Clin Oncol. 2024. PMID: 39673402
Characterization of PSA dynamics and oncological outcomes in patients with metastatic hormone-sensitive prostate cancer treated with androgen receptor signaling inhibitors.
Yamada Y, Sato K, Sakamoto S, Tsujino T, Saito S, Nishimura K, Fukushima T, Nakamura K, Yoshikawa Y, Matsunaga T, Maenosono R, Kanesaka M, Arai T, Sazuka T, Imamura Y, Komura K, Mikami K, Nakamura K, Fukasawa S, Chiba K, Naya Y, Nagata M, Komaru A, Nakatsu H, Azuma H, Ichikawa T. Yamada Y, et al. Among authors: imamura y. Int J Clin Oncol. 2024 Dec 10. doi: 10.1007/s10147-024-02676-z. Online ahead of print. Int J Clin Oncol. 2024. PMID: 39656401
Discriminant analysis of occupational performance characteristics in patients with major depressive disorders and healthy individuals.
Hayasaka T, Nagashima I, Hoshino M, Teruya K, Matumoto Y, Murao M, Maruki T, Watanabe M, Katagiri T, Imamura Y, Kurihara M, Oe Y, Takaesu Y, Tsuboi T, Watanabe K, Sakurai H. Hayasaka T, et al. Among authors: imamura y. PCN Rep. 2024 Nov 26;3(4):e70038. doi: 10.1002/pcn5.70038. eCollection 2024 Dec. PCN Rep. 2024. PMID: 39605926 Free PMC article.
1,886 results